| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5825355 | Clinical Therapeutics | 2014 | 4 Pages |
Abstract
Rituximab therapy is effective and safe for patients with corticosteroid-resistant ITP before splenectomy, resulting in high complete remission and overall response rates. A multicenter study with a larger sample should be performed to further explore the role of rituximab therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Cheng MD, Huan-Feng BA, Xing-Hua MD, Lei MD, Li MD, Yao MD, Pei-Yan MD, Ai-Hua BA, Xi MD,